Jiang, W., Li, G., Li, W., Wang, P., Xiu, P., Jiang, X., . . . Jiang, H. (2018). Sodium orthovanadate overcomes sorafenib resistance of hepatocellular carcinoma cells by inhibiting Na(+)/K(+)-ATPase activity and hypoxia-inducible pathways. Sci Rep.

Jiang, Wenjing, Guangxin Li, Weidong Li, Ping Wang, Peng Xiu, Xian Jiang, Bing Liu, Xueying Sun, and Hongchi Jiang. "Sodium Orthovanadate Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Cells By Inhibiting Na(+)/K(+)-ATPase Activity and Hypoxia-inducible Pathways." Sci Rep 2018.

Jiang, Wenjing, et al. "Sodium Orthovanadate Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Cells By Inhibiting Na(+)/K(+)-ATPase Activity and Hypoxia-inducible Pathways." Sci Rep 2018.